Načítá se...
GDNF is not required for catecholaminergic neuron survival in vivo
Glial cell line-derived neurotrophic factor (GDNF) has been tested in clinical trials to treat Parkinson’s disease with promising but variable results. Improvement of therapeutic effectiveness requires solid understanding of the physiological role of GDNF in the maintenance of the adult brain catech...
Uloženo v:
| Vydáno v: | Nat Neurosci |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878654/ https://ncbi.nlm.nih.gov/pubmed/25710828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3941 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|